Before asking Reflect Wellness and Aesthetics how much its weight-management program costs, ask which program you are entering. Its Tennessee practice and national telehealth offering do not have the same clinical structure or published pricing. Tennessee care comes through the practice’s own providers; national assessments come through an independent provider network. That distinction changes whom you should question about prescribing, follow-up, pharmacy selection and problems after enrollment.
This documentary review examines public documentation consulted October 19, 2026, with an emphasis on preparing for a useful conversation rather than choosing treatment for you. Reflect publishes meaningful details: local weekly price ranges, monthly monitoring, optional membership and several medication options. Other essentials remain unresolved, including national prices, named dispensing pharmacies and specific cancellation rules. Use these findings alongside a list of questions to ask before starting a GLP-1 program, and request written answers that apply to your particular location and offer.
At a glance
- Two different care pathways
- Reflect’s own providers deliver Tennessee clinic and Tennessee telehealth care. Independent providers conduct national assessments; Reflect says it does not prescribe through that program.Sources: [16]
- Local compounded medication prices
- Tennessee clinic prices are $25–$125 per week for compounded semaglutide and $75–$175 per week for compounded tirzepatide, each across six clinician-set tiers. Both pages disclose a $10 take-home fee without specifying its frequency.
- National pricing is separate
- The published menu contains Tennessee clinic cash-pay prices, not national package prices. National availability varies by state, and completing an assessment does not guarantee a prescription.
- Monthly clinical monitoring
- Reflect describes monthly visits and clinician-directed adjustments within program tiers, rather than a fixed adjustment schedule. The semaglutide page lists baseline health screening at consultation without naming specific laboratory tests.
- Important purchase terms come later
- Reflect’s general terms defer specific refund, cancellation and no-show rules to the terms presented when purchasing or booking. Separate clinical agreements govern care.Sources: [16]
Start with the identity of your treating practice
Reflect describes itself as a wellness practice with clinics in Murfreesboro and Franklin, Tennessee, owned and led by Dr. Brandon Hardin. Its five stated service categories are weight management, peptides, hormone therapy, aesthetics and IV therapy. This is a broader wellness business, not solely a weight-loss prescription website. For Tennessee residents, Reflect advertises both in-clinic appointments and telehealth visits with medication delivery across the state.
The clinician page identifies Danelle Farmer, NP, in Murfreesboro and Michelle Sloan, NP, in Franklin. Reflect describes Farmer as a board-certified nurse practitioner and Sloan as a board-certified family nurse practitioner, with weight management included in both clinicians’ care. Those are provider-published credential statements, not independently verified findings. Neither the practice’s ownership nor its clinician listings establish which person will conduct a particular patient’s consultation.
Outside Tennessee, the responsibility changes. Reflect’s terms say an independent network of licensed providers performs assessments through a partner telehealth platform; Reflect does not prescribe or control those providers’ medical judgment. The consulted documentation does not name that platform or network. Before submitting intake information, ask for the treating entity’s name, the clinician’s role and the organization responsible for ongoing care. A shared brand should not leave those responsibilities ambiguous.
Ask what your consultation actually establishes
Reflect describes an initial consultation and health screen covering medical history, goals and whether a program fits the patient’s plan. A consultation is required before treatment. Its semaglutide page also lists baseline health screening under a laboratory heading, but does not identify particular tests. Ask what screening entails, whether any laboratory work is required, who orders and reviews it, and whether testing or a separate consultation charge is included in the quote.
The website’s minimum age is 18 for using the site, booking services or submitting intake information. That is not a complete medication eligibility policy. The consulted pages do not provide a full set of clinical criteria or contraindications. National-program terms explicitly state that completing an assessment does not guarantee a prescription. It is worth establishing what you would owe if the evaluating clinician decides not to prescribe, rather than treating payment or intake completion as approval.
Prepare to discuss current medicines, supplements, allergies, health conditions and pregnancy plans, consistent with NIDDK’s guidance on medication decisions. Reflect’s consultation description supports a discussion of personal history, but does not document every question its clinicians ask. A consultation question list organized by topic can help you distinguish your medical concerns from administrative questions about charges and delivery. Neither a review nor a published price tier can determine your individual eligibility.
Get the exact medication offer, not just a program name
Reflect’s main injectable listings are compounded semaglutide and compounded tirzepatide. It describes semaglutide as a provider-guided GLP-1 injection program and tirzepatide as a dual GLP-1 and GIP injection program monitored by a licensed provider. The semaglutide page describes weekly self-administration and says the clinician explains how the medication is supplied and injected during consultation. These descriptions establish the advertised route, but not the exact vial presentation or supplies included in every purchase.
Two additional Tennessee-only programs combine ingredients. SkinT pairs compounded tirzepatide with B12 and L-carnitine in one weekly injection program; Xtra Skinny pairs compounded semaglutide with B12 and L-carnitine. Both advertise monthly clinician visits. Ask for the precise formulation and presentation on the prescription and dispensing label, and why that particular preparation is proposed. The names alone do not explain how a blend differs from the practice’s other compounded offerings or establish a clinical advantage.
FDA states that compounded preparations are not FDA approved and do not undergo its premarket review for safety, effectiveness and quality. Nonapproval alone does not prove clinical inequivalence. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. That makes the reason for compounding an important consultation question. Research on approved products does not establish outcomes for Reflect’s preparations or vitamin blends.
Turn the weekly menu into a written personal quote
Reflect’s local pricing is more specific than a single promotional starting price: its pages show ranges across clinician-selected tiers. Those prices are Tennessee clinic cash-pay prices, not national telehealth prices. The table preserves the weekly units and different program restrictions. A weekly advertised rate should not be silently converted into a calendar-month bill, and the number of tiers does not tell you how often the clinic collects payment or how much medication it supplies at once.
The standard semaglutide and tirzepatide pages each disclose a $10 take-home fee, but do not specify how often it applies. Reflect says the clinician confirms the full plan cost, including any take-home fee, before treatment begins. Ask for that confirmation in writing and have it identify consultation, follow-up, laboratory work, medication, injection supplies and shipping separately. The documentation does not establish that all these items are included in each weekly figure.
Reflect says it is direct-pay rather than insurance-covered, and membership is optional, never required. The semaglutide page advertises up to 15% off with membership, but the consulted documentation does not establish membership cost or conditions for receiving the maximum discount. National packages are priced separately. Before comparing offers, use questions that go beyond the monthly headline price to clarify the first collection, later charges and what happens financially when your clinician changes your tier.
| Offer | Published price | Important boundary |
|---|---|---|
| Compounded semaglutide injection | $25–$125 per week; six clinician-set tiers | Tennessee clinic cash-pay price; $10 take-home fee, frequency unspecified |
| Compounded tirzepatide injection | $75–$175 per week; six clinician-set tiers | Tennessee clinic cash-pay price; $10 take-home fee, frequency unspecified |
| SkinT: compounded tirzepatide with B12 and L-carnitine | $85–$185 per week; six clinician-set tiers | Weekly self-administered injection; Tennessee clinics only |
| Xtra Skinny: compounded semaglutide with B12 and L-carnitine | $35–$100 per week; five clinician-set tiers | Weekly self-administered injection; Tennessee clinics only |
| National telehealth packages | Priced separately; concrete prices not documented | State-dependent availability; do not apply Tennessee menu prices |
Clarify the pharmacy and delivery handoff
Reflect explicitly says it is not a pharmacy. It attributes prescribing to licensed medical providers and fulfillment to U.S.-licensed, FDA-registered pharmacies, including 503A compounding pharmacies. The semaglutide program page describes patient-specific prescriptions from a state-licensed 503A pharmacy. These are provider statements, not independent verification of a named facility. Pharmacy registration or regulation also does not make Reflect or a compounded preparation FDA approved; approval applies to a specific drug product.
For the national program, the terms say that an issued prescription is filled by a licensed 503A compounding pharmacy selected through the provider network. The consulted documentation does not identify those pharmacies by name. Reflect advertises online assessment and home delivery outside Tennessee where available, but state availability is not listed comprehensively. Ask whether your address is supported, which pharmacy will dispense your medicine, and whether you can obtain its contact details before paying.
No specific dispatch or arrival window, carrier, cold-chain process or damaged-delivery policy is documented in the consulted pages. Those are practical gaps to resolve before the first shipment, not proof that no procedures exist. FDA explicitly advises not using an injectable GLP-1 product that arrives warm or inadequately refrigerated and contacting the provider or dispensing pharmacy. Keep that instruction separate from any delivery estimate: an estimated shipping date does not establish acceptable arrival condition.
Find out how monthly care works between appointments
Reflect says monthly visits keep the plan matched to how the patient is doing, with clinician-directed adjustments within program tiers rather than a fixed schedule. That documents an ongoing monitoring model, not simply an initial prescription. Ask whether visits are in person or remote for your pathway, how they are scheduled, what happens if you miss one, and whether the same clinician usually follows you. The local description should not automatically be assumed to govern the independent national service.
Between-visit support is less clearly defined. The consulted pages do not establish response times, after-hours clinical availability or whether an additional encounter generates a charge. Reflect’s terms explicitly state that website forms, messages and booking tools are not monitored for urgent medical needs. Before starting, obtain the appropriate routine clinical contact and instructions for concerns that cannot wait for a website response. A booking tool’s existence is not evidence of a clinical monitoring service.
Reflect’s promise of injection education is especially relevant because FDA has received reports of measuring or administration errors involving compounded medications, including some associated with hospitalization. Ask the prescriber or pharmacist to resolve any uncertainty about your actual product’s instructions; do not derive dosing from a review. Our guide to questions about support after the first prescription can help separate refill administration, pharmacy questions and clinical follow-up so that each has a clear destination.
Keep optional additions separate from the core offer
Reflect lists standalone in-person B12 and L-carnitine injections at $10 each, available at Franklin and Murfreesboro. Their pages say they can be added during a consultation or follow-up without a separate appointment. A lipotropic injection is listed at $20, also as an in-person visit addition. Its specific blend is left for consultation rather than enumerated on the page. Ask which additions, if any, are being proposed and request an itemized quote rather than assuming they belong in the base program.
There is some access ambiguity: the B12 and L-carnitine pages describe additions to visits, while their FAQs allow obtaining them without a weight-management program. Confirm whether you need a separate service booking if that is what you want. More importantly for a GLP-1 consultation, distinguish these separately priced injections from the ingredients included in SkinT or Xtra Skinny. Similar ingredient names do not make the products, administration arrangements or billing interchangeable.
Other documented prescription options include phentermine tablets at $30 for 30 tablets and compounded ondansetron tablets at $6.99 for 15 or $10.99 for 30. Reflect presents these as clinician-reviewed options alongside weight management, not automatic inclusions. Ondansetron is explicitly Tennessee-clinic-only. Thirty phentermine tablets should not be described as a month’s supply without prescribing information. Ask why an additional medicine is proposed, what it costs separately and who will monitor it; this review does not establish whether either is appropriate for you.
Read the purchase-specific terms before authorizing payment
Reflect’s general terms defer specific refund, cancellation and no-show rules to the conditions presented when purchasing or booking. They also say separate clinical consents and agreements govern medical care. Request both sets of applicable documents before authorizing payment, particularly for the national pathway. The public documentation does not establish a universal cancellation deadline, automatic-renewal rule, minimum commitment or refund entitlement. Cancellation and refund are separate questions, and an optional membership does not answer either one.
The terms themselves are labeled a good-faith operational draft that has not yet been reviewed by an attorney and may change following legal review. That is a material documentary limitation, not a conclusion about enforceability. Ask for the current version and retain the version attached to your purchase. National payments use a third-party processor, while in-clinic services use clinic systems; the site says it does not store full payment-card details. Those processing statements do not establish billing intervals.
Communication preferences deserve a separate check. Reflect says consent to marketing texts is not a purchase condition and that recipients can reply STOP to opt out or HELP for assistance; message and data rates may apply. Marketing permissions should not be confused with clinical follow-up arrangements. Before enrolling, know how to withdraw promotional consent while retaining a reliable route for appointment, prescription and billing questions, and ask which organization handles each category in the national program.
Questions & answers
Can someone outside Tennessee enroll with Reflect?
Reflect advertises a national telehealth pathway with online assessment and home delivery where available. However, availability varies by state, and the consulted documentation does not provide a complete state list. Independent providers, not Reflect, perform national assessments and prescribe if appropriate. Confirm your state, treating entity and package price before paying; completing the assessment does not guarantee a prescription.
Is $25 per week the full price of Reflect semaglutide?
It is the bottom of the published Tennessee clinic range for compounded semaglutide injections: $25–$125 per week across six clinician-set tiers. The page also discloses a $10 take-home fee without stating its frequency. It is not a national price or a documented all-inclusive total. Reflect says the clinician confirms the full plan cost before treatment; request that breakdown in writing.
Do I have to buy a membership or use insurance?
Reflect states that membership is optional and that it operates on a direct-pay basis rather than through insurance coverage. The semaglutide page advertises up to 15% off with membership, but the consulted documentation does not establish membership dues or the conditions for the maximum discount. Ask for both the member and nonmember quote, including all fees, without assuming membership is required for treatment.
Does Reflect identify the pharmacy that will fill my prescription?
The consulted pages describe state-licensed 503A compounding pharmacies but do not identify a dispensing pharmacy by name. National terms say the provider network selects the pharmacy if a prescription is issued. Reflect itself is not a pharmacy. Ask for the actual dispensing facility’s name, contact information and product instructions, and clarify who handles a delivery problem before the medicine is shipped.
What is different about SkinT and Xtra Skinny?
SkinT combines compounded tirzepatide with B12 and L-carnitine; Xtra Skinny combines compounded semaglutide with those ingredients. Both are advertised as weekly self-administered injection programs with monthly visits, available only through Tennessee clinics. SkinT is $85–$185 per week across six tiers; Xtra Skinny is $35–$100 across five. Those descriptions do not establish that the blends outperform other formulations.
Can I cancel and receive a refund if I change my mind?
The general terms do not establish a universal right to either. Reflect says the purchase- or booking-specific refund, cancellation and no-show terms control over its general summary, while separate agreements govern care. Obtain those documents before paying and ask separately about stopping future charges, canceling appointments and refunding money already collected. Do not assume that permission to cancel also promises reimbursement.
Our assessment
Reflect provides a useful starting point for a patient conversation: identifiable Tennessee locations, named nurse practitioners, explicit local medication price ranges, monthly monitoring and a clear statement that national prescribing belongs to independent providers. Its documentation is less complete at the points where patients must commit money or manage a problem: national prices, named pharmacies, included services, delivery procedures and purchase-specific cancellation terms. The strongest next step is a written, pathway-specific explanation of who treats you, exactly what is prescribed, what each payment covers and whom to contact afterward. Reflect’s published details support informed questioning, but they do not independently verify credentials, pharmacy compliance, treatment quality or results. Whether the program fits depends on the clinical evaluation and the concrete terms offered to you.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Wilding et al. (2021): STEP 1 semaglutide trial ↗
- Jastreboff et al. (2022): SURMOUNT-1 tirzepatide trial ↗
- Reflect Wellness and Aesthetics — weight loss/programs/phentermine ↗
- Reflect Wellness and Aesthetics — weight loss/programs/lipotropic injection ↗
- Reflect Wellness and Aesthetics — weight loss/programs/glp 1 t ↗
- Reflect Wellness and Aesthetics — weight loss/programs/skint ↗
- Reflect Wellness and Aesthetics — weight loss/programs/xtra skinny ↗
- Reflect Wellness and Aesthetics — weight loss/programs/l carnitine injection ↗
- Reflect Wellness and Aesthetics — official website ↗
- Reflect Wellness and Aesthetics — weight loss/programs/ondansetron ↗
- Reflect Wellness and Aesthetics — weight loss/programs/glp 1 s ↗
- Reflect Wellness and Aesthetics — weight loss/programs/b12 injection ↗
- Reflect Wellness and Aesthetics — weight loss/programs ↗
- Reflect Wellness and Aesthetics — terms of service ↗